Tune Therapeutics is developing next-generation cell-therapies using their platform of targeted epigenetic modifiers.
Location: United States, North Carolina, Durham
Investors 3
Mentions in press and media 7
Date | Title | Description | Source |
01.05.2024 | Tune Therapeutics to test vaccine-like epigenetics platform | Duke University spinout Tune Therapeutics is rehearsing the overture of its avant-garde therapeutic ... | einpresswi... |
19.09.2023 | How Reed Jobs’ venture firm tackles cancer | Reed Jobs’ new venture firm can change the lives of the estimated 18.1 million diagnosed cancer pati... | techcrunch... |
11.04.2023 | Tech Moves: Adaptive Biotechnologies COO departing; Sana add... | Mark Adams. (Adaptive Photo) — Mark Adams is stepping down as chief operating officer of Adaptive Bi... | geekwire.c... |
10.04.2023 | Tech Moves: Halo leader departing; Remitly adds board direct... | Phyllis Campbell (left) and Ryno Blignaut. — Seattle-based fintech company Remitly added two new boa... | geekwire.c... |
02.12.2021 | Tune Therapeutics launches with $40M in funding, aims to fin... | Tune CEO Matt Kane. (Tune Photo) A new biotech startup with operations in Seattle and Durham, N.C., ... | geekwire.c... |
- | 9 top West Coast biotechs that VCs say are poised to take of... | Tayfun Coskun/Anadolu Agency/Getty Images This story is available exclusively to Insider subscribers... | businessin... |
- | Meet the 23 biotech startups that are set to take off in the... | Tyler Le/Insider This story is available exclusively to Insider subscribers. Become an Insider and s... | businessin... |